Litigation Details for Ferring B v. v. Watson Laboratories Inc. (Fed. Cir. 2014)

Ferring B v. v. Watson Laboratories Inc. (Fed. Cir. 2014)

Docket		Date Filed	2014-04-17
Court	Court of Appeals for the Federal Circuit	Date Terminated
Cause		Assigned To
Jury Demand		Referred To
Patents	6,066,339; 6,548,084; 6,551,616; 7,235,530; 7,947,739; 8,022,106; 8,273,795
Link to Docket	External link to docket

Details for Ferring B v. v. Watson Laboratories Inc. (Fed. Cir. 2014)

Date Filed	Document No.	Description	Snippet	Link To Document
2014-05-01	27		6,051,253 A 4/2000 Zettler 6,066,339 A 512000 Stark et al. …may be divided into three doses of 6,066,339, which is expressly incorporated by reference … EXHIBIT~ 6,066,339 A 5/2000 Stark et al. …doses. As an example, a total daily dose 35 6,066,339, which is expressly incorporated by reference …infringement of the patents-in-suit in this case as well as a related patent, U.S. Patent No. 8,478,005.	External link to document
2014-05-14	40		Ferring’s U.S. Patent Nos. 7,947,739 (“the ’739 patent”), 8,022,106 (“the ’106 patent”) and 8,273,795…The Asserted Patent Claims Claim 1 of the ’739 patent is illustrative of the patent claims at issue…regarding the patents at issue in this appeal, and an infringement claim regarding a different patent. …as Example 1 of the patents-in-suit, and its own ANDA documents and patent application detail …the asserted patent claims, and also meet the dissolution limitations of the patent claims. 3	External link to document